Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £56.68m
KMK Live PriceLast checked at - London Stock Exchange

Intraday Kromek Share Chart

Contract Win

4 Aug 2014 07:00

RNS Number : 1000O
Kromek Group PLC
04 August 2014
 



Embargoed until: 07.00, 4 August 2014

 

 

Kromek Group plc

("Kromek" or "the Company")

 

 

Kromek Awarded Network Detector Development Programme by the US Defence Advanced Research Projects Agency

 

 

Kromek (AIM: KMK.L), a supplier of patented radiation detection technologies to the medical, security and nuclear markets, is pleased to announce that it has been awarded up to $1.23m for a 12-month programme with the U.S. Defense Advanced Research Projects Agency (DARPA) commencing immediately. This is to develop an advanced portable detection system for gamma and neutron radiation that can be combined in large networks, providing information on radiation signatures over an extended area. The programme is geared towards procurement in Year 2 and beyond. DARPA is an agency of the United States Department of Defense and responsible for maintaining the technological superiority of the U.S. military.

 

This contract, along with many others in the nuclear detection market, represents further healthy conversion of the pipeline into orders and the majority of the revenue of the contract is expected to be recognised in the current financial year.

These latest successes are rooted both in Kromek's world leading capabilities in high performance radiation detectors, which are compact and uniquely require no cooling mechanism, and also in its overall "semiconductor to solutions" business model. This allows the Company to quickly respond to emerging customer needs by understanding and integrating all the closely interlocking elements required for an end customer application. These elements often include the detector design, different system configurations and software components, to allow improved interpretation and presentation of data in an easy-to-use and efficient form. Over the last few years the Company has introduced a number of products into the nuclear detection market, each providing unique performance, field usability and reduced size, including the world's smallest, high resolution gamma ray spectrometer operating at room temperature. This is used for a wide range of applications such as nuclear decommissioning, environmental monitoring and remote sensing on board ground-based robotics and Unmanned Aerial Vehicles.  

Commenting on the award, Kromek CEO Dr Arnab Basu said, "Kromek is delighted to receive this award from DARPA, which closely follows recent awards from other areas of the U.S. Government and is further recognition of the advances Kromek's detector technology platforms are making into growing global markets."

 

-ends-

 

 

For further information, please contact:

 

Kromek Group plc

Arnab Basu, CEO

Derek Bulmer, CFO

 

Tel: 01740 626060

Panmure Gordon

As Nominated Adviser and Broker

Corporate Finance

Freddy Crossley

Broking

Charles Leigh-Pemberton

 

Tel: 020 7886 2500

Tavistock Communications

John West

Andrew Dunn

Tel: 020 7920 3150

 

About Kromek Group plc

Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

Kromek uses multiple technologies in its manufacturing processes, including the established methods of 'liquid phase' detector production, and also 'vapour phase' production methods, which allow the production of high quality, high performance detectors on an industrial scale. Kromek has an intellectual property portfolio of more than 250 pieces of IP.

The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Board believes that the vertical integration offered by Kromek, combined with the benefit of 25 years of research into CZT production and the patents and trade secrets accumulated by the Group, are unparalleled in the market place.

 

The Group has operations in the UK, Germany and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over a hundred full time employees across its global operations.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUGUMCRUPCGQG
Date   Source Headline
14th Feb 20175:39 pmRNSHolding(s) in Company
14th Feb 20175:25 pmRNSDirector/PDMR Shareholding
14th Feb 20172:27 pmRNSHolding(s) in Company
14th Feb 201710:31 amRNSHolding(s) in Company
13th Feb 20172:04 pmRNSDirector/PDMR Shareholding
10th Feb 20173:19 pmRNSDirector/PDMR Shareholding
10th Feb 201711:51 amRNSResults of Firm Placing, Open Offer and GM
2nd Feb 20174:38 pmRNSHolding(s) in Company
1st Feb 20175:18 pmRNSHolding(s) in Company
26th Jan 201711:42 amRNSHolding(s) in Company
25th Jan 20177:00 amRNSFirm Placing and Open Offer to raise up to £21m
24th Jan 201710:15 amRNSTotal Voting Rights
22nd Dec 201611:05 amRNSSecond Price Monitoring Extn
22nd Dec 201611:00 amRNSPrice Monitoring Extension
7th Dec 20167:00 amRNSInterim Results
24th Nov 20162:15 pmRNSHolding(s) in Company
18th Nov 201612:15 pmRNSNotice of Results
2nd Nov 20167:00 amRNSNew BMD orders from existing OEM customers
19th Oct 20167:00 amRNSDelivery of 10,000 units of D3S to DARPA
17th Oct 20167:00 amRNSSix New Contract Wins Across All Business Segments
30th Sep 201612:22 pmRNSBlock listing Interim Review
21st Sep 201612:33 pmRNSResult of AGM
9th Sep 201611:46 amRNSBlock Admission
26th Aug 20163:24 pmRNSNotice of AGM and Posting of Annual Report
3rd Aug 20164:13 pmRNSHolding(s) in Company
1st Aug 20161:09 pmRNSPublication of Annual Report
29th Jul 201612:37 pmRNSTotal Voting Rights
20th Jul 201610:06 amRNSDirector/PDMR Shareholding
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSHolding(s) in Company
28th Apr 20167:00 amRNSNew $12.6m contract with existing OEM customer
15th Apr 20161:27 pmRNSTotal Voting Rights
15th Apr 20161:25 pmRNSBlock listing Interim Review
14th Mar 20167:00 amRNSDirector Share Purchase
25th Feb 201611:12 amRNSHolding(s) in Company
22nd Feb 20167:00 amRNSKromek awarded further $748K contract by DARPA
22nd Feb 20167:00 amRNSSole source supplier contract from DARPA
18th Feb 20164:05 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSCapital Markets Day
20th Jan 20167:00 amRNSNew contract with long-standing customer
22nd Dec 201511:29 amRNSDirector Share Purchase
16th Dec 20157:00 amRNSDirectorate Changes
16th Dec 20157:00 amRNSInterim Results
1st Dec 20157:00 amRNSKromek enters partnership with CANBERRA Industries
5th Nov 20157:00 amRNSCross Licensing Agreement
23rd Oct 201512:49 pmRNSResult of AGM
8th Oct 20157:00 amRNSDARPA Sole Source Notice
30th Sep 20151:53 pmRNSNotice of AGM and Posting of Annual Report
28th Sep 20152:18 pmRNSBlocklisting Interim Review
28th Sep 20157:00 amRNSAppointment of Sir Peter Williams CBE as Chairman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.